Deals & Cases

07/12/2019

On July 9, 2019, ADC Therapeutics SA, an oncology drug discovery and development company that specializes in the development of Antibody Drug Conjugates (ADCs) targeting major cancers, announced that it had raised an aggregate of USD 103 m through a private placement of shares, bringing the total gross proceeds of its Series E financing round to USD 303 m.


Homburger advised ADC Therapeutics SA in this matter. The Homburger team is led by partner Dieter Gericke (Corporate | M&A) and included partner Reto Heuberger (Tax) as well as associates Daniel Häusermann and Anna Peter and junior associate Nicolas Eckert (all Corporate | M&A).